TABLE OF CONTENTS 
1 INTRODUCTION
1.1 MARKET DEFINITION

1.2 MARKET SEGMENTATION

1.3 RESEARCH TIMELINES

1.4 ASSUMPTIONS

1.5 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 DATA MINING

2.2 SECONDARY RESEARCH

2.3 PRIMARY RESEARCH

2.4 SUBJECT MATTER EXPERT ADVICE

2.5 QUALITY CHECK

2.6 FINAL REVIEW

2.7 DATA TRIANGULATION

2.8 BOTTOM-UP APPROACH

2.9 TOP-DOWN APPROACH

2.10 RESEARCH FLOW
3 EXECUTIVE SUMMARY
3.1 MARKET OVERVIEW

3.2 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET GEOGRAPHICAL ANALYSIS (CAGR %)

3.3 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION (USD MILLION)

3.4 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER (USD MILLION)

3.5 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICE (USD MILLION)

3.6 FUTURE MARKET OPPORTUNITIES

3.7 GLOBAL MARKET SPLIT
4 MARKET OUTLOOK
4.1 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET OUTLOOK
4.2 MARKET DRIVERS
4.2.1 INCREASING PREFERENCE FOR CELL-BASED ASSAYS IN DRUG DISCOVERY

4.2.2 GROWING FUNDING FOR CELL-BASED RESEARCH AND GROWTH IN THE NUMBER OF DRUG DISCOVERY ACTIVITIES
4.3 MARKET RESTRAINTS
4.3.1 SHORTAGE OF SKILLED EXPERTS & COST ASSOCIATED WITH DRUG DISCOVERY SERVICES
4.4 MARKET OPPORTUNITIES
4.4.1 EMERGING ASIAN MARKETS
4.5 TRENDS
4.5.1 NEXT DIMENSION OF CELL-BASED ASSAYS
4.6 IMPACT OF COVID – 19 ON CELL-BASED DRUG DISCOVERY SERVICES MARKET
4.7 PERCENT VOLUME OF CELL-BASED SERVICES IN THE DRUG DISCOVERY SERVICES MARKET
5 MARKET, BY APPLICATION
5.1 OVERVIEW
5.2 DRUG DISCOVERY
5.2.1 TOXICITY STUDIES

5.2.2 PHARMACOKINETIC STUDIES

5.2.3 PHARMACODYNAMIC STUDIES
5.3 MEDICAL RESEARCH
6 MARKET, BY END-USER
6.1 OVERVIEW

6.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

6.3 RESEARCH AND ACADEMIC INSTITUTES
7 MARKET, BY TYPE OF SERVICE
7.1 OVERVIEW

7.2 NUCLEAR RECEPTOR ASSAY SERVICES

7.3 ION CHANNEL ASSAY SERVICES

7.4 G-PROTEIN-COUPLED RECEPTOR (GPCR) ASSAY SERVICES

7.5 CELL-BASED FUNCTIONAL ASSAY SERVICES

7.6 ADVANCED CELL CULTURE SERVICES

7.7 INTERLEUKIN SCREENING & PROFILING SERVICES

7.8 OTHERS
8 MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT

8.2.2 U.S.

8.2.2.1 U.S.MARKET SNAPSHOT

8.2.3 CANADA

8.2.3.1 CANADA MARKET SNAPSHOT

8.2.1 MEXICO

8.2.1.1 MEXICO MARKET SNAPSHOT
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT

8.3.2 GERMANY

8.3.2.1 GERMANY MARKET SNAPSHOT

8.3.3 U.K.

8.3.3.1 U.K.MARKET SNAPSHOT

8.3.4 FRANCE

8.3.4.1 FRANCE MARKET SNAPSHOT

8.3.5 REST OF EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT

8.4.2 CHINA

8.4.2.1 CHINA MARKET SNAPSHOT

8.4.3 JAPAN

8.4.3.1 JAPAN MARKET SNAPSHOT

8.4.4 INDIA

8.4.4.1 INDIA MARKET SNAPSHOT

8.4.5 REST OF ASIA PACIFIC
8.5 ROW
8.5.1 ROW MARKET SNAPSHOT

8.5.2 MIDDLE EAST & AFRICA

8.5.3 LATIN AMERICA
9 COMPETITIVE LANDSCAPE
9.1 COMPETITIVE SCENARIO

9.2 COMPANY MARKET RANKING ANALYSIS
10 COMPANY PROFILES
10.1 THERMO FISHER SCIENTIFIC INC.
10.1.1 COMPANY OVERVIEW

10.1.2 COMPANY INSIGHTS

10.1.1 SEGMENT BREAKDOWN

10.1.2 PRODUCT BENCHMARKING

10.1.3 KEY DEVELOPMENTS

10.1.4 SWOT ANALYSIS
10.2 EUROFINS DISCOVERX
10.2.1 COMPANY OVERVIEW

10.2.2 COMPANY INSIGHTS

10.2.3 SEGMENT BREAKDOWN

10.2.4 PRODUCT BENCHMARKING

10.2.5 KEY DEVELOPMENTS

10.2.6 SWOT ANALYSIS
10.3 LONZA GROUP
10.3.1 COMPANY OVERVIEW

10.3.2 COMPANY INSIGHTS

10.3.3 SEGMENT BREAKDOWN

10.3.4 PRODUCT BENCHMARKING

10.3.5 KEY DEVELOPMENTS

10.3.6 SWOT ANALYSIS
10.4 LABORATORY CORPORATION OF AMERICA HOLDINGS
10.4.1 COMPANY OVERVIEW

10.4.2 COMPANY INSIGHTS

10.4.3 SEGMENT BREAKDOWN

10.4.4 PRODUCT BENCHMARKING

10.4.5 KEY DEVELOPMENTS
10.5 CHARLES RIVER LABORATORIES INTERNATIONAL
10.5.1 COMPANY OVERVIEW

10.5.2 COMPANY INSIGHTS

10.5.3 SEGMENT BREAKDOWN

10.5.4 PRODUCT BENCHMARKING

10.5.5 KEY DEVELOPMENTS
10.6 WUXI APPTEC
10.6.1 COMPANY OVERVIEW

10.6.2 COMPANY INSIGHTS

10.6.3 SEGMENT BREAKDOWN

10.6.4 PRODUCT BENCHMARKING

10.6.5 KEY DEVELOPMENTS
10.7 SYNGENE INTERNATIONAL LIMITED
10.7.1 COMPANY OVERVIEW

10.7.2 COMPANY INSIGHTS

10.7.3 PRODUCT BENCHMARKING

10.7.4 KEY DEVELOPMENTS
10.8 GENSCRIPT BIOTECH CORPORATION
10.8.1 COMPANY OVERVIEW

10.8.2 COMPANY INSIGHTS

10.8.3 SEGMENT BREAKDOWN

10.8.4 PRODUCT BENCHMARKING
10.9 CREATIVE BIOARRAY
10.9.1 COMPANY OVERVIEW

10.9.2 COMPANY INSIGHTS

10.9.3 PRODUCT BENCHMARKING
10.10 SYGNATURE DISCOVERY
10.10.1 COMPANY OVERVIEW

10.10.2 COMPANY INSIGHTS

10.10.3 PRODUCT BENCHMARKING
LIST OF TABLES
TABLE 1 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2021 – 2028 (USD MILLION)

TABLE 2 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY DRUG DISCOVERY, 2021 – 2028 (USD MILLION)

TABLE 3 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER, 2021 – 2028 (USD MILLION)

TABLE 4 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICE, 2021 – 2028 (USD MILLION)

TABLE 5 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY GEOGRAPHY, 2021 – 2028 (USD MILLION)

TABLE 6 NORTH AMERICA CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2021 – 2028 (USD MILLION)

TABLE 7 NORTH AMERICA CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2021 – 2028 (USD MILLION)

TABLE 8 NORTH AMERICA CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER, 2021 – 2028 (USD MILLION)

TABLE 9 NORTH AMERICA CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICE, 2021 – 2028 (USD MILLION)

TABLE 10 U.S. CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2021 – 2028 (USD MILLION)

TABLE 11 U.S. CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER, 2021 – 2028 (USD MILLION)

TABLE 12 U.S. CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2021 – 2028 (USD MILLION)

TABLE 13 CANADA CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2021 – 2028 (USD MILLION)

TABLE 14 CANADA CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER, 2021 – 2028 (USD MILLION)

TABLE 15 CANADA CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2021 – 2028 (USD MILLION)

TABLE 16 MEXICO CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2021 – 2028 (USD MILLION)

TABLE 17 MEXICO CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER, 2021 – 2028 (USD MILLION)

TABLE 18 MEXICO CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICE, 2021 – 2028 (USD MILLION)

TABLE 19 EUROPE CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2021 – 2028 (USD MILLION)

TABLE 20 EUROPE CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2021 – 2028 (USD MILLION)

TABLE 21 EUROPE CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER, 2021 – 2028 (USD MILLION)

TABLE 22 EUROPE CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2021 – 2028 (USD MILLION)

TABLE 23 GERMANY CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2021 – 2028 (USD MILLION)

TABLE 24 GERMANY CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER, 2021 – 2028 (USD MILLION)

TABLE 25 GERMANY CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2021 – 2028 (USD MILLION)

TABLE 26 U.K. CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2021 – 2028 (USD MILLION)

TABLE 27 U.K. CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER, 2021 – 2028 (USD MILLION)

TABLE 28 U.K. CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2021 – 2028 (USD MILLION)

TABLE 29 FRANCE CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2021 – 2028 (USD MILLION)

TABLE 30 FRANCE CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER, 2021 – 2028 (USD MILLION)

TABLE 31 FRANCE CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2021 – 2028 (USD MILLION)

TABLE 32 REST OF EUROPE CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2021 – 2028 (USD MILLION)

TABLE 33 REST OF EUROPE CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER, 2021 – 2028 (USD MILLION)

TABLE 34 REST OF EUROPE CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2021 – 2028 (USD MILLION)

TABLE 35 ASIA PACIFIC CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2021 – 2028 (USD MILLION)

TABLE 36 ASIA PACIFIC CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2021 – 2028 (USD MILLION)

TABLE 37 ASIA PACIFIC CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER, 2021 – 2028 (USD MILLION)

TABLE 38 ASIA PACIFIC CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2021 – 2028 (USD MILLION)

TABLE 39 CHINA CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2021 – 2028 (USD MILLION)

TABLE 40 CHINA CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER, 2021 – 2028 (USD MILLION)

TABLE 41 CHINA CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2021 – 2028 (USD MILLION)

TABLE 42 JAPAN CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2021 – 2028 (USD MILLION)

TABLE 43 JAPAN CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER, 2021 – 2028 (USD MILLION)

TABLE 44 JAPAN CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2021 – 2028 (USD MILLION)

TABLE 45 INDIA CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2021 – 2028 (USD MILLION)

TABLE 46 INDIA CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER, 2021 – 2028 (USD MILLION)

TABLE 47 INDIA CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2021 – 2028 (USD MILLION)

TABLE 48 REST OF ASIA PACIFIC CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2021 – 2028 (USD MILLION)

TABLE 49 REST OF ASIA PACIFIC CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER, 2021 – 2028 (USD MILLION)

TABLE 50 REST OF ASIA PACIFIC CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2021 – 2028 (USD MILLION)

TABLE 51 ROW CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2021 – 2028 (USD MILLION)

TABLE 52 ROW CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2021 – 2028 (USD MILLION)

TABLE 53 ROW CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER, 2021 – 2028 (USD MILLION)

TABLE 54 ROW CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2021 – 2028 (USD MILLION)

TABLE 55 MIDDLE EAST & AFRICA CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2021 – 2028 (USD MILLION)

TABLE 56 MIDDLE EAST & AFRICA CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER, 2021 – 2028 (USD MILLION)

TABLE 57 MIDDLE EAST & AFRICA CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2021 – 2028 (USD MILLION)

TABLE 58 LATIN AMERICA CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2021 – 2028 (USD MILLION)

TABLE 59 LATIN AMERICA CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER, 2021 – 2028 (USD MILLION)

TABLE 60 LATIN AMERICA CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2021 – 2028 (USD MILLION)

TABLE 61 COMPANY MARKET RANKING ANALYSIS

TABLE 62 THERMO FISHER SCIENTIFIC INC.: PRODUCT BENCHMARKING

TABLE 63 THERMO FISHER SCIENTIFIC INC.: KEY DEVELOPMENTS

TABLE 64 EUROFINS DISCOVERX: PRODUCT BENCHMARKING

TABLE 65 EUROFINS DISCOVERX: KEY DEVELOPMENTS

TABLE 66 LONZA GROUP: PRODUCT BENCHMARKING

TABLE 67 LONZA GROUP: KEY DEVELOPMENTS

TABLE 68 LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCT BENCHMARKING

TABLE 69 LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY DEVELOPMENTS

TABLE 70 CHARLES RIVER LABORATORIES INTERNATIONAL: PRODUCT BENCHMARKING

TABLE 71 CHARLES RIVER LABORATORIES INTERNATIONAL: KEY DEVELOPMENTS

TABLE 72 WUXI APPTEC: PRODUCT BENCHMARKING

TABLE 73 WUXI APPTEC: KEY DEVELOPMENTS

TABLE 74 SYNGENE INTERNATIONAL LIMITED: PRODUCT BENCHMARKING

TABLE 75 SYNGENE INTERNATIONAL LIMITED: KEY DEVELOPMENTS

TABLE 76 GENSCRIPT BIOTECH CORPORATION: PRODUCT BENCHMARKING

TABLE 77 CREATIVE BIOARRAY: PRODUCT BENCHMARKING

TABLE 78 SYGNATURE DISCOVERY: PRODUCT BENCHMARKING
LIST OF FIGURES
FIGURE 1 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET SEGMENTATION

FIGURE 2 RESEARCH TIMELINES

FIGURE 3 DATA TRIANGULATION

FIGURE 4 MARKET RESEARCH FLOW

FIGURE 5 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET OVERVIEW

FIGURE 6 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET GEOGRAPHICAL ANALYSIS, 2021-2028

FIGURE 7 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION (USD MILLION)

FIGURE 8 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER (USD MILLION)

FIGURE 9 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICE (USD MILLION)

FIGURE 10 FUTURE MARKET OPPORTUNITIES

FIGURE 11 NORTH AMERICA DOMINATED THE MARKET IN 2020

FIGURE 12 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET OUTLOOK

FIGURE 13 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY APPLICATION

FIGURE 14 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY END-USER

FIGURE 15 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICE

FIGURE 16 GLOBAL CELL-BASED DRUG DISCOVERY SERVICES MARKET, BY GEOGRAPHY, 2021 – 2028 (USD MILLION)

FIGURE 17 KEY STRATEGIC DEVELOPMENTS

FIGURE 18 THERMO FISHER SCIENTIFIC INC.: COMPANY INSIGHT

FIGURE 19 THERMO FISHER SCIENTIFIC INC.: BREAKDOWN

FIGURE 20 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS

FIGURE 21 EUROFINS DISCOVERX: COMPANY INSIGHT

FIGURE 22 EUROFINS DISCOVERX: BREAKDOWN

FIGURE 23 EUROFINS DISCOVERX: SWOT ANALYSIS

FIGURE 24 LONZA GROUP: COMPANY INSIGHT

FIGURE 25 LONZA GROUP: BREAKDOWN

FIGURE 26 LONZA GROUP: SWOT ANALYSIS

FIGURE 27 LABORATORY CORPORATION OF AMERICA HOLDINGS.: COMPANY INSIGHT

FIGURE 28 LABORATORY CORPORATION OF AMERICA HOLDINGS: BREAKDOWN

FIGURE 29 CHARLES RIVER LABORATORIES INTERNATIONAL: COMPANY INSIGHT

FIGURE 30 CHARLES RIVER LABORATORIES INTERNATIONAL: BREAKDOWN

FIGURE 31 WUXI APPTEC: COMPANY INSIGHT

FIGURE 32 WUXI APPTEC: BREAKDOWN

FIGURE 33 SYNGENE INTERNATIONAL LIMITED: COMPANY INSIGHT

FIGURE 34 GENSCRIPT BIOTECH CORPORATION: COMPANY INSIGHT

FIGURE 35 GENSCRIPT BIOTECH CORPORATION: BREAKDOWN

FIGURE 36 CREATIVE BIOARRAY: COMPANY INSIGHT

FIGURE 37 SYGNATURE DISCOVERY: COMPANY INSIGHT

The research starts with the extensive procurement process of data/information and statistics from company annual reports, government websites, statistics agencies, and paid databases. This information creates a base for the study. The information also helps to define the scope and to narrow down the area for study for the market. This raw information is processed and analyzed to extract crisp data points which currently affect or are likely to affect the industry during the forecast period. After analyzing the information, a proprietary statistical tool is used for market estimation and forecast, which generates the quantitative figures of the market/sub-segments in the current scenario as well as for the forecast period. 

After estimating the markets and estimates, the numbers are verified with industry participants and key opinion leaders. The wide network of industry participants add value to the research and verify the numbers and estimates provided in the study. At the last stage of the research process, a final report is prepared, which is then published on different websites as well as distributed through various channels. The below figure contains the different stages of the research process to produce the report.

1.1 DATA MINING
Data mining is an extensive part of our research process. It involves the procurement of market data and related information from different verified and credible sources. This step helps to obtain raw information about the industry and their Drivetrain, the monetary process for different end uses, the pool of market participants, and the nature of the industry and scope of the study. The data mining stage comprises both primary and secondary sources of information.
1.2 SECONDARY RESEARCH
In the secondary research process, various sources are used to identify and gather industry trends and information for the research process. We at TRI have access to some of the most diversified and extensive paid databases, which give us the most accurate data/information on markets Customers, and pricing. Mentioned below is a detailed list of sources that have been used for this study. Please note that this list is not limited to the names as mentioned; we also access other data sources depending on the need.
1.3 PRIMARY RESEARCH
In the primary research process, in-depth primary interviews are conducted with the CXOs to understand the market share, customer base, pricing strategies, channel partners, and other necessary information. Besides, in-depth primary interviews are conducted with the CXOs of vendors, channel partners, and others to validate the supply-side information. In addition, various key industry participants from both the supply and demand side are interviewed to obtain qualitative and quantitative information on the market. In-depth interviews with key primary respondents, including industry professionals, subject matter experts (Corporates), industry consultants, and C-Component executives of major companies, are conducted to obtain critical qualitative and quantitative information pertaining to the market, as well as to assess the prospects for market growth during the forecast period. Detailed information on these primary respondents is mentioned below. 
1.4 FORCASTING TECHNIQUES
We at Markstats Research Insights Private Limited follow an extensive process for arriving at market estimations, which involves the use of multiple forecasting techniques as mentioned below.